Midfacelift – an effective way to rejuvenate the mid-face without an unnatural look
Introduction
Midfacelift, or mid-face lift, is a minimally invasive surgical procedure that allows for spectacular yet natural rejuvenation of the cheek area, lower eyelids, and nasolabial folds. Unlike a traditional facelift, this procedure does not create a "mask" effect, but subtly restores the facial contours of years past.
What is a midfacelift?
Midfacelift focuses on:
- elevation of cheek tissues,
- smoothing the lower eyelid,
- reduction of nasolabial folds,
- Restoration of volume in the central part of the face.
The procedure is usually performed through small incisions in the natural temporal folds or under the lower eyelid, which minimizes scar visibility. The surgeon detaches and lifts the facial tissues upwards, often securing them to deep structures (e.g., the temporal fascia).
For whom is midfacelift intended?
The treatment is ideal for people:
- aged 35–55
- with visibly sagging cheeks,
- in whom the nasolabial folds began to deepen,
- but the skin is still in relatively good condition.
Course of treatment
- The procedure is performed under general anesthesia or local anesthesia with sedation.
- It usually lasts 1.5–2.5 hours.
- Stitches are removed after about 7 days.
- Return to normal activity is possible after 10–14 days.
Comparison of effects across different beauty types
Advantages of a mid-facelift
- A natural rejuvenation effect without artificial tautness.
- Shorter recovery than with a classic facelift
- Duration of effects – typically 5 to 10 years
- Option of combining with blepharoplasty or lipotransfer
Comparison table: mid-facelift vs. other techniques
Recovery after mid-facelift
Contraindications
- Advanced chronic diseases
- Tendency to keloids
- Pregnancy and Lactation
- Skin diseases at the treatment site
Combination with other treatments
Midfacelift is often combined with:
- blepharoplasty (eyelid correction),
- lipotransfer to the cheeks,
- a forehead or temple lift,
- regenerative treatments such as platelet-rich plasma.


